5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)

NCT01038635 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: 5-Azacytidine
DRUG: Lenalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]